Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sriram Sathyanarayanan

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Genes & Development|June 19, 2007
Post-translational regulation of the Drosophila circadian clock requires protein phosphatase 1 (PP1)Yanshan Fang, Sriram Sathyanarayanan, Amita Sehgal
Cell|February 26, 2004
Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2ASriram Sathyanarayanan, Xiangzhong Zheng, Rui Xiao, et al.
Sleep|May 25, 2007
Interaction between sleep and the immune response in Drosophila: a role for the NFkappaB relishJulie A Williams, Sriram Sathyanarayanan, Joan C Hendricks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 29, 2003
Novel insights into the regulation of the timeless proteinLesley J Ashmore, Sriram Sathyanarayanan, David W Silvestre, et al.
Genes & Development|June 4, 2008
Identification of novel genes involved in light-dependent CRY degradation through a genome-wide RNAi screenSriram Sathyanarayanan, Xiangzhong Zheng, Shailesh Kumar, et al.
BMC Cancer|October 22, 2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancerMarc A Becker, Xiaonan Hou, Piyawan Tienchaianada, et al.
Frontiers in Oncology|July 30, 2014
Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growthJolijn W Groeneweg, Celeste M DiGloria, Jing Yuan, et al.
Gynecologic Oncology|March 29, 2017
Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumorsAmy Bregar, Amit Deshpande, Chris Grange, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
Science Advances|February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activitySushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Genes & Development|June 19, 2007
Post-translational regulation of the Drosophila circadian clock requires protein phosphatase 1 (PP1)Yanshan Fang, Sriram Sathyanarayanan, Amita Sehgal
Cell|February 26, 2004
Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2ASriram Sathyanarayanan, Xiangzhong Zheng, Rui Xiao, et al.
Sleep|May 25, 2007
Interaction between sleep and the immune response in Drosophila: a role for the NFkappaB relishJulie A Williams, Sriram Sathyanarayanan, Joan C Hendricks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 29, 2003
Novel insights into the regulation of the timeless proteinLesley J Ashmore, Sriram Sathyanarayanan, David W Silvestre, et al.
Genes & Development|June 4, 2008
Identification of novel genes involved in light-dependent CRY degradation through a genome-wide RNAi screenSriram Sathyanarayanan, Xiangzhong Zheng, Shailesh Kumar, et al.
BMC Cancer|October 22, 2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancerMarc A Becker, Xiaonan Hou, Piyawan Tienchaianada, et al.
Frontiers in Oncology|July 30, 2014
Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growthJolijn W Groeneweg, Celeste M DiGloria, Jing Yuan, et al.
Gynecologic Oncology|March 29, 2017
Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumorsAmy Bregar, Amit Deshpande, Chris Grange, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
Science Advances|February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activitySushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Pageof 2